Fundz

Brise Pharmaceuticals raises nearly $20M in series pre-A and pre-A+ financing

PRIVATEApr 23, 2024

Amount Raised

$20 Million

Round Type

Funding Round

ShanghaiBiotechnologyHealth CareTherapeuticsPharmaceutical

Investors

Sherpa Healthcare PartnersBio Track CapitalQiming Venture PartnersVinner TherapeuticsCnfuel CapitalShunxi Fund

Description

Brise Pharmaceuticals recently completed Pre-A and Pre-A+ financing with a total of approximately $20 million. The funds raised will be used to advance the company’s product pipeline in the preclinical and clinical stages, as well as to further refine and validate the Trigeminovascular System (TVS) biology-based drug development platform and the Dorsal Root Ganglion (DRG) biology-based drug development platform.

Quick answer

Brise Pharmaceuticals LTD raised $20 Million in a Funding Round round, dated April 23, 2024. Investors: Sherpa Healthcare Partners, Bio Track Capital, Qiming Venture Partners, Vinner Therapeutics, Cnfuel Capital and Shunxi Fund. Brise Pharmaceuticals LTD is based in Shanghai, Shanghai, China.

How much did Brise Pharmaceuticals LTD raise?
Brise Pharmaceuticals LTD raised $20 Million in a Funding Round round on April 23, 2024.
Who invested in Brise Pharmaceuticals LTD?
Sherpa Healthcare Partners, Bio Track Capital, Qiming Venture Partners, Vinner Therapeutics, Cnfuel Capital and Shunxi Fund are named as investors in this round.
What does Brise Pharmaceuticals LTD do?
Brise Pharmaceuticals is a pioneering company specializing in innovative treatments for acute and chronic pain.
Where is Brise Pharmaceuticals LTD based and how big is it?
Brise Pharmaceuticals LTD is based in Shanghai, Shanghai, China.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Brise Pharmaceuticals LTD that raised within 45 days of this round, from Fundz verified event records.

  • Bicycle Therapeutics raised $555M on May 28, 2024.
  • Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
  • Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
  • Cerenome, Inc. raised $18M (Post-IPO Equity) on May 6, 2024.
  • Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
  • TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.

Who to call at Brise Pharmaceuticals LTD, and when

A new round usually means Brise Pharmaceuticals LTD is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Brise Pharmaceuticals LTD raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Brise Pharmaceuticals LTD, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Brise Pharmaceuticals LTD. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Brise Pharmaceuticals LTD

Location

Shanghai, Shanghai, China

About

Brise Pharmaceuticals is a pioneering company specializing in innovative treatments for acute and chronic pain. Led by CEO Dr. Guochun Li, the company has a singular focus on the development of innovative and highly differentiated analgesic treatments for debilitating pain conditions with large unmet needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Brise Pharmaceuticals LTD raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Brise Pharmaceuticals LTD's next move

See what Strategic adds

Brise Pharmaceuticals LTD raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.